The biotech firm raises its outlook after Q1 2026 progress in partner milestones boosts revenue visibility.
OmniAb Inc. (OABI) expects 2026 revenue between $28M and $33M, driven by advancements in partner programs. The updated forecast reflects stronger pipeline visibility and milestone achievements in early-stage collaborations.
The company previously did not provide a full-year revenue range for 2026. Q1 2026 performance exceeded internal expectations, with management citing accelerated partner program development as the primary catalyst.
No immediate market reaction was disclosed in the earnings call summary.